Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Income towards Parent Company (2019 - 2021)

Inventiva (IVEVF) posted Income towards Parent Company of -$11.9 million for Q2 2021, down 167.99% on a QoQ basis from -$4.4 million in Q1 2021, and down 22.57% year-over-year from -$15.4 million in Q2 2020.

Analysis

Inventiva (IVEVF) Income towards Parent Company (2019 - 2021) Analysis & Trends

Inventiva has reported Income towards Parent Company for 3 years, with the latest figure at -$11.9 million in Q2 2021.

  • On a quarterly basis, Income towards Parent Company fell 22.57% year-over-year to -$11.9 million in Q2 2021; TTM through Jun 2021 was -$66.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $93.2 million, up 1703.95% from the prior year.
  • Income towards Parent Company was -$11.9 million for Q2 2021 at Inventiva, down from -$4.4 million in the prior quarter.
  • The five-year high for Income towards Parent Company was -$4.4 million in Q1 2021, with the low at -$40.1 million in Q4 2020.
  • Average Income towards Parent Company over 3 years is -$17.8 million, with a median of -$10.8 million recorded in 2020.
  • The largest YoY upside for Income towards Parent Company was 40.67% in 2021 against a maximum downside of 22.57% in 2021.
  • Over 3 years, Income towards Parent Company stood at -$33.4 million in 2019, then slipped by 20.07% to -$40.1 million in 2020, then jumped by 70.36% to -$11.9 million in 2021.
  • The last three Income towards Parent Company figures came in at -$11.9 million (Q2 2021), -$4.4 million (Q1 2021), and -$40.1 million (Q4 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 642.70 Bn 621.95 Bn 17.26 Bn
2 AbbVie 440.80 Bn 434.23 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.37 Bn 258.68 Bn 11.24 Bn
5 Pfizer 158.89 Bn 147.19 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.38 Bn 44.38 Bn -
8 Incyte 25.28 Bn 20.74 Bn 1.57 Bn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn
10 Inventiva 693.72 Mn 693.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -11.89 Mn
Mar 31, 2021 -4.44 Mn
Dec 31, 2020 -40.11 Mn
Jun 30, 2020 -9.70 Mn
Mar 31, 2020 -7.48 Mn
Dec 31, 2019 -33.40 Mn